GlobalData on MSN23h
FDA grants ODD status to Zai Lab’s lung cancer treatment
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).
Cantor Fitzgerald Weighs in on Zai Lab FY2025 Earnings
Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Zai Lab in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst L. Chen forecasts that the ...
MT Newswires on MSN23h
Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading
Asian equities traded in the US as American depositary receipts were edging lower on Thursday morning, down 0.2% to 2,123.24 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by ...
FY2025 Earnings Estimate for UNH Issued By Cantor Fitzgerald
Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for UnitedHealth Group in a ...